<?xml version="1.0" encoding="UTF-8"?>
<abstract abstract-type="author-highlights" id="ab0015">
 <title>Highlights</title>
 <p>
  <list list-type="simple" id="l0110">
   <list-item id="li0230">
    <label>•</label>
    <p id="p0230">COVID-19 patients with underlying CVD have drastically increased risks of mortality.</p>
   </list-item>
   <list-item id="li0235">
    <label>•</label>
    <p id="p0235">SARS-CoV2 uses ACE2 as cell entry receptor.</p>
   </list-item>
   <list-item id="li0240">
    <label>•</label>
    <p id="p0240">Current and novel COVID-19 drugs may act on the SARS-CoV-2 receptor ACE2.</p>
   </list-item>
   <list-item id="li0245">
    <label>•</label>
    <p id="p0245">ACE-I and ARB may interfere with COVID-19 susceptibility and effects on the heart.</p>
   </list-item>
  </list>
 </p>
</abstract>
